Brent Willis is CEO of Voyageur Pharmaceuticals Ltd., building a new pharmaceutical industry in Western Canada. Voyageur owns three barium projects in B.C., including one with a resource estimate, Iodine properties in Utah, has a Joint Venture with privately held Chief Medical Supplies Ltd. (a Canadian pharmaceutical manufacturing and distribution company) to manufacture and market contrast agents (made with barium and/or iodine compounds) used for radiology digital imaging in the healthcare industry. In this podcast, Brent discusses the challenges of operating his business during the COVID-19 pandemic and how remote working actually increased efficiency and will become the new norm for his business.
Related Podcasts
The key to a long career in pharmaceutical R&D
Dr. Allen Davidoff is the founder and CEO of XORTX. Allen has 15 years of drug development experience across...
Connecting medical cannabis patients, licensed producers and processors
Joel Taylor, Co-founder of Patient Choice, has been at the forefront of the ever-changing cannabis industry for many years....
Lessons learned from legend Wayne Gretzky applied to MRI technology company
In the podcast, Sean Krakiwsky talks about his hockey playing days and lessons learned from legend Wayne Gretzky. Nanalysis...